Carbapenem-resistant Enterobacteriaceae, (CRE) was first identified in 2001, and has
been found in 4.6% of all hospitals in the United States. CRE is very difficult to
treat and is a threat in all hospitals if aggressive prevention measures are not rapidly
instituted to protect staff, patients and visitors A proactive program emphasizing
the areas of education, surveillance, isolation and prevention is the key to combat
the spread of this infection in acute care facilities.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
Publication Number 401
Identification
Copyright
© 2014 Published by Elsevier Inc.
